Rehab robotics unicorn Fourier Intelligence is continuing to develop its global presence through its latest strategic partnership with MyndTec.
Fourier has announced a partnership with Canadian MyndTec, which will focus on the distribution of its award-winning MyndMove™ therapy.
The non-invasive electrical stimulation-based intervention is now part of Fourier’s ever-expanding global network, which also comprises growing numbers of life-changing robotic devices for patients.
Fourier’s global network now spans over 50 countries, with joint laboratories with some of the top research institutes in the world such as ETH Zürich, University of Melbourne, and Shirley Ryan AbilityLab in Chicago.
“Our partnership with MyndTec signifies yet another successful strategic collaboration with market leaders to offer innovative and clinically effective technology for our patients globally,” said Zen Koh, co-founder and Global HQ CEO of Fourier Intelligence.
Fourier Intelligence’s RehabHub
“MyndMove™, an electrical stimulation-based intervention, integrates perfectly into Fourier’s RehabHub™ solution and complement our existing product/technology portfolio.
“Fourier will continue our investment into more of such joint technological developments to better provide highly integrated intelligent rehabilitation technologies to empower clinicians and patients.”
The partnership was confirmed through a virtual signing ceremony, involving MyndTec’s CEO, Craig Leon; co-founder, Dr Milos R. Popovic; with Fourier Intelligence’s Zen Koh, general manager Owen Teoh, and operations director Sandra Lee, all attending the event.
This partnership comes as both parties reach strategic milestones.
Fourier Intelligence recently received a Series D growth investment led by the SoftBank Group and backed by the Saudi Aramco P7 Venture Fund and the Yuanjing Capital, to help fuel its further growth.
MyndTec began trading on the Canadian Securities Exchange (CSE) on February 24th, under the ticker symbol MYTC.
“We are excited to enter into this meaningful partnership with Fourier Intelligence to strategically integrate our MyndMove™ technology into RehabHub™,” said Craig Leon, CEO of MyndTec.
“Fourier’s proven track record in establishing globally successful RehabHub™, positively changing patient lives globally and the addition of MyndTec’s innovative MyndMove™ therapy to this network, will enable us to reach out to more patients worldwide.”
MyndTec’s medical devices are designed to improve function, maximise independence, and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or some cases of traumatic brain injury.
It also partners with several organisations such as the KITE Research Institute, the research arm of the Toronto Rehabilitation Institute – University Health Network and the University of Toronto to develop and commercialise MyndMove™ therapy.
